Cancer News and Research

Latest Cancer News and Research

IDT's new xGen Prism DNA Library Prep Kit launched

Integrated DNA Technologies, a leading comprehensive genomics solutions provider, has launched the xGen Prism DNA Library Prep Kit, designed to produce high-quality Next Generation Sequencing data from precious but challenging samples, assisting in the early detection of cancer mutations and other applications.

From Integrated DNA Technologies 24 Feb 2020

New methods to decipher how natural substances affect the body’s hormone balance

A team of researchers from Vienna has developed methods of deciphering precisely how plants and medicinal substances affect the body’s own hormone balance. Initial analyses show that in high doses some natural substances promote the growth of breast cancer cells.

24 Feb 2020

Hormone blocker shocker: Drug costs 8 times more when used for kids

Dr. Sudeep Taksali, an orthopedic surgeon, became worried that his 8-year-old daughter had already grown taller than his 12-year-old son. And sometimes she had an attitude more befitting a teenager. Something seemed wrong.

24 Feb 2020

Discovery may open up new avenues into improving cancer immunotherapy

New cancer immunotherapy approaches are revolutionizing treatment options for breast cancer patients. However, many lead to insufficient immune responses rendering the therapies incapable of completely eradicating tumors.

23 Feb 2020

UT Dallas scientists awarded CPRIT grants for lung, kidney cancer research

The Cancer Prevention and Research Institute of Texas has awarded new grants totaling $1.8 million to two University of Texas at Dallas scientists for their research related to lung and kidney cancers.

23 Feb 2020

Lipid signaling from beta cells linked to inflammatory macrophage polarization

Do the insulin-producing beta cells in the pancreas unwittingly produce a signal that aids their own demise in Type 1 diabetes?

23 Feb 2020

Researchers develop new probe to detect common target of anti-inflammatory drugs

The Chan group at the Beckman Institute for Advanced Science and Technology has recently developed a probe named CoxFluor, which is able to distinguish between Cyclooxygenase-2, an enzyme that plays a major role in driving the progression of cancer, and Cyclooxygenase-1, which is expressed in all cells.

23 Feb 2020

Researchers study why colon cancer is more lethal in pediatric and young adult patients

Colon cancer is more likely to be lethal in children and young adults than middle-aged adults. In a single-institution study, researchers at The University of Texas MD Anderson Cancer Center, Houston, Tex., found that differences in mortality rates persist regardless of whether pediatric, adolescent, and young adult patients (aged 24 and younger) were born with a predisposition for colon abnormalities or disease and for the first time conclude that young people are more likely to have metastases outside the colon, into the abdominal cavity, when they are diagnosed.

23 Feb 2020

Advances in surgical care for patients with pancreatic cancer

Earlier this year, doctors and researchers celebrated the news that the five-year survival rate for pancreatic cancer had crossed into double digits for the first time - up from just 6% in 2011.

23 Feb 2020

Coriell researchers find new genetic indicator of obesity risk

Obesity is among the most common complex diseases in the United States and has been a stubborn public health challenge for decades. Its causes are wide ranging, but genetic heritability is increasingly understood to be an influential factor in determining a person's risk for the disease.

23 Feb 2020

UCI makes tremendous strides in prevention, early detection and treatment of cancer

Like most people, John Gifford wasn't looking forward to a colonoscopy when he arrived on the UCI Medical Center campus in Orange in 2018.

23 Feb 2020

UCI neuro-oncologist uses comprehensive approach to battle brain cancer

When you're facing a cancer diagnosis with an average survival span of 12 to 18 months, every milestone is a victory.

23 Feb 2020

New evidence-based clinical guidelines for surgical treatment of thyroid disease

The first set of comprehensive, evidence-based clinical guidelines for surgical treatment of thyroid disease - developed by an expert panel assembled by the American Association of Endocrine Surgeons - was published today by Annals of Surgery.

23 Feb 2020

Novel discovery about enzymes ensures efficient DNA repair

DNA is the hereditary material in humans, a unique cookbook of who we are. This is where you'll find the answer as to why you have your specific eye and hair color, or perhaps why you sunburn easily.

23 Feb 2020

Using newly discovered immune cell type to fight pancreatic cancer

Immunotherapy is showing great promise for treating cancer. But so far, this approach has been effective in only about 20% of all cancers. To advance those results, researchers are looking for new ways to mobilize the immune system to destroy tumors.

23 Feb 2020

Comprehensive tumor profiling reveals why osteosarcoma does not respond to immunotherapy

Comprehensive profiling of tumor samples taken from patients with osteosarcoma shows that multiple factors contribute to the traditionally poor responses observed from treatment with immune checkpoint inhibitors, according to new research from The University of Texas MD Anderson Cancer Center.

22 Feb 2020

Bariatric surgery also effective for individuals with early-onset obesity

Surgical treatment of obesity is as effective for individuals who developed the disorder early, by the age of 20, as for those who have developed obesity later in life, a study from the University of Gothenburg shows.

21 Feb 2020

Isolating Single T-cells of Interest using an Optofluidic Platform

Researchers are in desperate need of single-cell analysis techniques and those that allow the isolation of high-value T-cells for research and development.

From Bruker Cellular Analysis 21 Feb 2020

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer.

21 Feb 2020

Tulane establishes COVID-19 research program to develop a vaccine and test treatments

From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new therapeutic strategies and nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.

21 Feb 2020

Cancer News and Research

Latest Cancer News and Research

IDT's new xGen Prism DNA Library Prep Kit launched

New methods to decipher how natural substances affect the body’s hormone balance

Hormone blocker shocker: Drug costs 8 times more when used for kids

Discovery may open up new avenues into improving cancer immunotherapy

UT Dallas scientists awarded CPRIT grants for lung, kidney cancer research

Lipid signaling from beta cells linked to inflammatory macrophage polarization

Researchers develop new probe to detect common target of anti-inflammatory drugs

Researchers study why colon cancer is more lethal in pediatric and young adult patients

Advances in surgical care for patients with pancreatic cancer

Coriell researchers find new genetic indicator of obesity risk

UCI makes tremendous strides in prevention, early detection and treatment of cancer

UCI neuro-oncologist uses comprehensive approach to battle brain cancer

New evidence-based clinical guidelines for surgical treatment of thyroid disease

Novel discovery about enzymes ensures efficient DNA repair

Using newly discovered immune cell type to fight pancreatic cancer

Comprehensive tumor profiling reveals why osteosarcoma does not respond to immunotherapy

Bariatric surgery also effective for individuals with early-onset obesity

Isolating Single T-cells of Interest using an Optofluidic Platform

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Tulane establishes COVID-19 research program to develop a vaccine and test treatments

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in